Is There a Consensus About Lock Downs?

3min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

There are still also other parts of the immune system that we still don't have a really clear understanding of, how they might respond to variant sycomacron and tea cells. And there is ongrowing research into those as well, to work out what protection might be afforded by those parts of theimmune system. It's not going o vad all our immunity, and hopefully what's, what's left will keep people out of hospital. We'll probably deal with it like we do other viruses indeed.

Several weeks after the Omicron variant was first identified, it has quickly spread across the world. Early data are showing clear signals that the latest variant of concern is able to evade immunity and spread at a rate faster than any other variant to date. But many questions remain unanswered about the severity of infection, the protection afforded by natural and vaccine-derived immunity, and the impact Omicron could have on the global pandemic response. In this episode, we delve into the very latest studies to take stock of where we are so far and, in a Coronapod first, take on questions sent in by Coronapod listeners.

News: How bad is Omicron? What scientists know so far

News: Omicron likely to weaken COVID vaccine protection

News: Omicron-variant border bans ignore the evidence, say scientists

News Feature: Beyond Omicron: what’s next for COVID’s viral evolution

Subscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday.

Hosted on Acast. See acast.com/privacy for more information.